| Line 5: | Line 5: | ||
*This page is for referencing possible therapeutic (medicinal) '''benefits''' of nicotine. | *This page is for referencing possible therapeutic (medicinal) '''benefits''' of nicotine. | ||
==Addiction / Abuse Liability (Nicotine)== | ==Addiction / Abuse Liability / Dependence (Nicotine)== | ||
===2021 [https://onlinelibrary.wiley.com/doi/10.1111/add.15403 Dependence on nicotine in US high school students in the context of changing patterns of tobacco product use]=== | |||
*Among US high school students, increases in the prevalence of nicotine product use from 2012 to 2019 do not appear to have been accompanied by a similar increase in the population burden of nicotine dependence. This may be at least partly attributable to a shift in the most common product of choice from cigarettes (on which users are most dependent) to e-cigarettes (on which users are least dependent). | |||
*[https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.15403 PDF Version] | |||
*Citation: Jackson, S. E., Brown, J., and Jarvis, M. J. (2021) Dependence on nicotine in US high school students in the context of changing patterns of tobacco product use. Addiction, 116: 1859– 1870. doi: 10.1111/add.15403 | |||
*Acknowledgement: Cancer Research UK (C1417/A22962) supported S.J. andJ.B.’s salaries. | |||
edits